FILTER BY:
Details
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors
Address: 20 Duke Medicine Cir, Durham, NC 27710, USA
Phone: 877-451-7009
Mesothelioma Type:
- Pleural: False
- Peritoneal: False
- Pericardial: False
- Tunica Vaginalis: False
Type: N/A
Condition: Clear Cell Renal Cell Carcinoma, Cervical Carcinoma, Esophageal Carcinoma, Pancreatic Adenocarcinoma, Malignant Pleural Mesothelioma
Description: This is an open-label, multicenter, Phase 1/2 study evaluating the safety and efficacy of CTX131™ in subjects with relapsed or refractory solid tumors.
Research Center: Duke Cancer Institute
Treatment Interventions: BIOLOGICAL: CTX131
Potential Impact: Fake Data
Clinical Trial Number: NCT05795595
Phase: Phase 1, Phase 2
Status: Recruiting
